Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma K Persson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Mabs|May 4, 2026
Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibodyLaura Bracke, Heidi Gytz Olesen, Erwin Pannecoucke, et al.
Nature Communications|August 16, 2025
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubartInge Van de Walle, Laura Bracke, Heidi Gytz Olesen, et al.
Immunity|April 13, 2016
IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell HomeostasisKatarzyna M Luda, Thorsten Joeris, Emma K Persson, et al.
Frontiers in Immunology|November 3, 2018
Intestinal CD103<sup>+</sup>CD11b<sup>+</sup> cDC2 Conventional Dendritic Cells Are Required for Primary CD4<sup>+</sup> T and B Cell Responses to Soluble FlagellinAdriana Flores-Langarica, Charlotte Cook, Katarzyna Müller Luda, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Mabs|May 4, 2026
Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibodyLaura Bracke, Heidi Gytz Olesen, Erwin Pannecoucke, et al.
Nature Communications|August 16, 2025
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubartInge Van de Walle, Laura Bracke, Heidi Gytz Olesen, et al.
Immunity|April 13, 2016
IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell HomeostasisKatarzyna M Luda, Thorsten Joeris, Emma K Persson, et al.
Frontiers in Immunology|November 3, 2018
Intestinal CD103<sup>+</sup>CD11b<sup>+</sup> cDC2 Conventional Dendritic Cells Are Required for Primary CD4<sup>+</sup> T and B Cell Responses to Soluble FlagellinAdriana Flores-Langarica, Charlotte Cook, Katarzyna Müller Luda, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
Pageof 2